Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.98 USD | +0.04% | +0.06% | +240.92% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.92% | 4.46B | |
+8.59% | 114B | |
+10.80% | 104B | |
-12.90% | 22.41B | |
-1.19% | 22.28B | |
-5.24% | 19.07B | |
-38.29% | 18B | |
-5.05% | 17.89B | |
+7.57% | 14.28B | |
+35.84% | 12.55B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Transcript : Alpine Immune Sciences, Inc., Q4 2020 Earnings Call, Mar 18, 2021